Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $12.37 $15.43 Thursday, 9th May 2024 URGN stock ended at $12.97. This is 2.26% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 4.81% from a day low at $12.60 to a day high of $13.21.
90 days $12.37 $19.87
52 weeks $8.69 $24.13

Historical UroGen Pharma Ltd prices

Date Open High Low Close Volume
Mar 13, 2018 $56.74 $56.87 $53.71 $55.58 102 085
Mar 12, 2018 $57.44 $58.66 $56.33 $56.94 60 237
Mar 09, 2018 $56.35 $57.86 $55.57 $57.07 68 619
Mar 08, 2018 $55.46 $56.81 $55.01 $56.00 56 177
Mar 07, 2018 $55.06 $56.81 $54.62 $55.50 42 018
Mar 06, 2018 $56.86 $57.25 $54.66 $56.62 87 055
Mar 05, 2018 $54.43 $57.75 $53.50 $56.67 205 763
Mar 02, 2018 $52.59 $54.79 $51.51 $54.13 102 590
Mar 01, 2018 $52.31 $53.27 $51.16 $53.12 118 421
Feb 28, 2018 $49.06 $53.78 $49.00 $52.66 171 625
Feb 27, 2018 $50.50 $50.89 $49.11 $49.86 52 343
Feb 26, 2018 $50.74 $52.19 $49.20 $50.32 93 995
Feb 23, 2018 $50.00 $50.99 $48.70 $50.91 57 179
Feb 22, 2018 $50.70 $51.98 $49.26 $49.83 93 925
Feb 21, 2018 $50.33 $52.70 $49.87 $50.93 119 821
Feb 20, 2018 $48.54 $50.41 $46.81 $50.00 257 798
Feb 16, 2018 $50.12 $50.41 $46.79 $47.92 114 841
Feb 15, 2018 $51.61 $51.61 $48.61 $50.08 175 725
Feb 14, 2018 $49.53 $51.30 $49.00 $50.64 180 197
Feb 13, 2018 $49.74 $50.00 $47.58 $49.58 127 018
Feb 12, 2018 $47.50 $50.73 $47.12 $50.00 107 655
Feb 09, 2018 $49.09 $49.26 $46.20 $47.60 114 297
Feb 08, 2018 $49.84 $50.84 $47.56 $48.89 139 954
Feb 07, 2018 $50.92 $51.00 $48.47 $50.11 147 169
Feb 06, 2018 $44.96 $51.11 $44.15 $51.00 209 672
Click to get the best stock tips daily for free!

About UroGen Pharma Ltd

UroGen Pharma Ltd UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102, which is in Phase III clinical trials for the treatment of several forms... URGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT